INTRODUCTION
============

All polynucleotide chain elongation reactions, whether with DNA or RNA, proceed in the 5′-3′ direction. This reaction involves the nucleophilic attack of a 3′-OH of the terminal nucleotide in the elongating chain on the α-phosphate of an incoming nucleotide. The energy in the high-energy bond of the incoming nucleotide is used for its addition \[termed tail polymerization ([@R1])\]. This elongation reaction of DNA/RNA chains is in clear contrast to the elongation of protein chains in which the high energy of the incoming aminoacyl-tRNA is not used for its own addition but for the addition of the next monomer (termed head polymerization). However, recent studies have shown that the Thg1/Thg1-like protein (TLP) family of proteins extends tRNA nucleotide chains in the reverse (3′-5′) direction ([@R2], [@R3]). In this case, the 5′-end of tRNA is first activated using adenosine 5′-triphosphate (ATP)/guanosine 5′-triphosphate (GTP), followed by nucleophilic attack of a 3′-OH on the incoming nucleotide \[nucleoside 5′-triphosphate (NTP)\] to yield pppN-tRNA. Thus, the energy in the triphosphate bond of the incoming nucleotide is not used for its own addition but is reserved for subsequent polymerization (that is, head polymerization) ([Fig. 1](#F1){ref-type="fig"}).

![Reaction schemes of 3′-5′ and 5′-3′ elongation.\
**Top:** Reaction scheme of 3′-5′ elongation by Thg1/TLP family proteins. **Bottom:** Reaction scheme of 5′-3′ elongation by DNA/RNA polymerases. In 3′-5′ elongation by Thg1/TLP family proteins, the 5′-monophosphate of the tRNA is first activated by ATP/GTP, followed by the actual elongation reaction. The energy of the incoming nucleotide is not used for its own addition but is reserved for the subsequent addition (head polymerization). In 5′-3′ elongation by DNA/RNA polymerases, the energy of the incoming nucleotide is used for its own addition (tail polymerization).](1501397-F1){#F1}

The best-characterized member of this family of proteins is eukaryotic Thg1 (tRNA^His^ guanylyltransferase), which catalyzes the nontemplated addition of a guanylate to the 5′-end of immature tRNA^His^ ([@R4]). This guanosine at position −1 (G~−1~) of tRNA^His^ is a critical identity element for recognition by the histidyl-tRNA synthase ([@R5]--[@R8]). Therefore, Thg1 is essential to the fidelity of protein synthesis in eukaryotes. However, Thg1 homologs or TLPs are found in organisms in which G~−1~ is genetically encoded, and thus, posttranscriptional modification is not required ([@R9], [@R10]). This finding suggests that TLPs may have potential functions other than tRNA^His^ maturation. TLPs have been shown to catalyze 5′-end nucleotide addition to truncated tRNA species in vitro in a Watson-Crick template--dependent manner ([@R11]). This function of TLPs is not limited to tRNA^His^ but occurs efficiently with other tRNAs. Furthermore, the yeast homolog (Thg1p) has been shown to interact with the replication origin recognition complex for DNA replication ([@R12]), and the plant homolog (ICA1) was identified as a protein affecting the capacity to repair DNA damage ([@R13]). These observations suggest that TLPs may have more general functions in DNA/RNA repair ([@R3], [@R9], [@R11]).

The 3′-5′ addition reaction catalyzed by Thg1 occurs through three reaction steps ([@R4], [@R14]). In the first step, the 5′-monophosphorylated tRNA^His^, which is cleaved by ribonuclease P from pre-tRNA^His^, is activated by ATP, creating a 5′-adenylylated tRNA^His^ intermediate. In the second step, the 3′-OH of the incoming GTP attacks the activated intermediate, yielding pppG~−1~-tRNA^His^. Finally, the pyrophosphate is removed, and mature pG~−1~-tRNA^His^ is created. The crystal structure of human Thg1 (*Hs*Thg1) ([@R15]) shows that its catalytic core shares structural homology with canonical 5′-3′ nucleotide polymerases, such as T7 DNA/RNA polymerases ([@R16], [@R17]). This finding suggests that 3′-5′ elongation enzymes are related to 5′-3′ polymerases and raises important questions on why 5′-3′ polymerases predominate in nature. The crystal structure of TLP from *Bacillus thuringiensis* shows that it shares a similar tetrameric assembly and active-site architecture with *Hs*Thg1 ([@R18]). Furthermore, the structure of *Candida albicans* Thg1 (*Ca*Thg1) complexed with tRNA^His^ reveals that the tRNA substrate accesses the reaction center from a direction opposite to that of canonical DNA/RNA polymerase ([@R19]). However, in this structural analysis, the 5′-end of tRNA^His^ was not activated and the second substrate (GTP) was not bound. Thus, a detailed reaction mechanism remains unknown.

Here, we successfully solved the structure of TLP from the methanogenic archaeon *Methanosarcina acetivorans* (*Ma*TLP) in complex with ppptRNA^Phe^Δ~1~, which mimics the activated intermediate of the repair substrate. Although TLP and Thg1 have similar tetrameric organization, the mode of tRNA binding is different in TLP. Furthermore, we obtained the structure in which the GTP analog (GDPNP) was inserted into this complex to form a Watson-Crick base pair with C~72~ at the 3′-end region of the tRNA. On the basis of these structures, we discuss the reaction mechanism of template-dependent reverse (3′-5′) polymerization in comparison with canonical 5′-3′ polymerization.

RESULTS
=======

Anticodon-independent binding of ppptRNA^Phe^Δ~1~ to *Ma*TLP
------------------------------------------------------------

Previous biochemical experiments have suggested that ppptRNA^Phe^Δ~1~, in which the 5′-end of tRNA^Phe^ was triphosphorylated and G~1~ was deleted, can be an efficient substrate for the repair reaction (guanylyl transfer) of Thg1/TLP ([@R4], [@R10], [@R20]). Therefore, we prepared a crystal of *Ma*TLP complexed with ppptRNA^Phe^Δ~1~ and solved its structure to study the template-directed 3′-5′ elongation reaction by TLP (fig. S1). The crystal contained a dimer of TLP (A and B molecules) and one tRNA in an asymmetric unit. Two dimers in the crystal further assembled as a dimer of dimers by the crystallographic twofold axis ([Fig. 2](#F2){ref-type="fig"}). This tetrameric structure and 4:2 stoichiometry of the TLP-tRNA complex are the same as those of the *Ca*Thg1-tRNA complex ([@R19]). However, whereas the AB and CD dimers of tetrameric *Ca*Thg1 play different roles, respectively recognizing the accepter stem and anticodon of tRNA^His^ ([@R19]), the AB dimer and its symmetry mate (CD dimer) on tetrameric *Ma*TLP independently bind one molecule of tRNA (fig. S2), recognizing the tRNA accepter stem and elbow region. Thus, consistent with the notion that *Ma*TLP is an anticodon-independent repair enzyme ([@R11]), the anticodon was not recognized in the *Ma*TLP-tRNA complex, whereas the binding mode of *Ca*Thg1 is for the G~−1~ addition reaction, therefore the His anticodon has to be recognized (see "Dual binding mode for tRNA repair").

![Structure of the *Ma*TLP complex with ppptRNA^Phe^Δ~1~.\
**Left:** One molecule of the tRNA substrate (ppptRNA^Phe^Δ~1~) is bound to the *Ma*TLP dimer. The AB and CD dimers are further dimerized by the crystallographic twofold axis to form a tetrameric structure (dimer of dimers). **Right:** Left figure rotated by 90^o^. The CD dimer is omitted for clarity. The accepter stem of the tRNA is recognized by molecule A (yellow), and the elbow region by molecule B (blue). Residues important for binding are depicted in stick form. The β-hairpin region of molecule B is shown in red.](1501397-F2){#F2}

The elbow region of the tRNA substrate was recognized by the β-hairpin of molecule B of *Ma*TLP. The N atoms in the side chain of R215 in the β-hairpin region of *Ma*TLP were hydrogen-bonded to the phosphate groups of U~55~ and G~57~. The O atom on the S213 side chain was also hydrogen-bonded to the phosphate moiety of G~57~ of the tRNA ([Fig. 2](#F2){ref-type="fig"}). This β-hairpin region was disordered in the crystal structure of the *Ca*Thg1-tRNA complex.

The accepter stem of the tRNA substrate was recognized by molecule A of *Ma*TLP. The N7 atom of G~2~ at the 5′-end was hydrogen-bonded to the N atom of the R136 side chain, whereas the α-phosphate was bonded to the N137 side chain ([Fig. 2](#F2){ref-type="fig"}). R136 was also hydrogen-bonded to the base of C~72~ (the Watson-Crick bond partner of ΔG~1~). The triphosphate moiety at the 5′-end of the tRNA was bonded to the D21-K26 region. These phosphates were also coordinated to two metal ions, presumably Mg^2+^ (Mg^2+^A and Mg^2+^B) because they were observed at the same positions (figs. S3 and S4) previously identified by *Ca*Thg1 ([@R19]) and *Hs*Thg1 structures ([@R15]). These ions were in turn coordinated by the O atoms of the side chains of D21 and D69 and the main-chain O of G22 (fig. S3A). Mutation of D29 and D76 in *Hs*Thg1 (corresponding to D21 and D69 of *Ma*TLP) has been shown to markedly decrease G~−1~ addition activity ([@R15]).

Template-dependent binding of the GTP analog to the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex
------------------------------------------------------------------------------------

Here, we successfully obtained the structure of the ternary complex of *Ma*TLP, 5′-activated tRNA (ppptRNA^Phe^Δ~1~), and the GTP analog (GDPNP) ([Fig. 3](#F3){ref-type="fig"} and fig. S4) by soaking the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex crystal in a solution containing GDPNP. The obtained structure showed that the guanine base of the incoming GDPNP formed Watson-Crick hydrogen bonds with C~72~ and accompanied base-stacking interactions with G~2~ of the tRNA ([Fig. 3B](#F3){ref-type="fig"}), whereas no interaction was observed between the guanine base and the enzyme. These features are consistent with the fact that this elongation reaction is template-dependent. The 5′-end (position 2) of the tRNA moved significantly ([Fig. 3C](#F3){ref-type="fig"}) due to the insertion of GDPNP. Surprisingly, the 5′-triphosphate moiety after movement occupied the GTP/ATP triphosphate position during the activation step ([Fig. 3D](#F3){ref-type="fig"}). Together with the observation that the 3′-OH of the incoming GTP analog was within coordination distance (2.8 Å) to Mg^2+^A (fig. S3B) and was able to execute a nucleophilic attack on the α-phosphate of the 5′-end, this structure indicates that the elongation reaction (second reaction) takes place at the same reaction center where the activation reaction (first reaction) occurs.

![Structural change of the tRNA (ppptRNA^Phe^Δ~1~).\
Structural change of the tRNA (ppptRNA^Phe^Δ~1~) accepter stem in *Ma*TLP caused by insertion of GDPNP. (**A**) Structure before GDPNP binding. (**B**) Structure after GDPNP binding. (**C**) Superposition of the two structures showing movement of the 5′-end of the tRNA before (blue) and after (red) insertion of GDPNP. (**D**) Superposition of the 5′-end of the tRNA after GDPNP insertion (red) with GTP at the activation step (green), showing that both triphosphate moieties superpose well.](1501397-F3){#F3}

The triphosphate moiety of GDPNP was at the interface between molecules A and B and was recognized by the side chains of both molecules, including R19 (molecule A), R83 (molecule B), K86 (molecule B), and R114 (molecule A) ([Fig. 3B](#F3){ref-type="fig"}). All of these residues are well conserved (fig. S5), and mutation of corresponding residues in *Sc*Thg1 (R27, R93, K96, and R133) decreased the catalytic efficiency of G~−1~ addition ([@R21]). The triphosphate of the GDPNP was also bonded to the third Mg^2+^ (Mg^2+^C), which, unlike Mg^2+^A and Mg^2+^B, is not coordinated by the TLP molecule (fig. S3B). This triphosphate binding mode is the same as that for the second nucleotide binding site in Thg1. However, in previous analyses, the base moiety at the second site was either invisible ([@R15]) or far beyond the reaction distance of the phosphate, and therefore, flipping of the base was expected to occur ([@R19]).

tRNA binding and repair experiments of the β-hairpin mutants
------------------------------------------------------------

To confirm tRNA recognition by the β-hairpin, we created mutation variants with altered residues in the β-hairpin region. Then, tRNA binding and enzymatic activities were measured. β-Hairpin deletion variant delR198-R215 almost completely abolished the binding of tRNA^Phe^Δ~1~ (fig. S6). Furthermore, the enzymatic activities of delR198-R215 and delG202-E210 were very weak (5.2 and 13.5%, respectively) compared with wild type, whereas mutations (N179A and F174A/N179A/R188A) on the anticodon recognition site \[deduced from the Thg1-tRNA^His^ complex structure ([@R19])\] had no effect on the catalytic activity ([Fig. 4A](#F4){ref-type="fig"}). Experiments using the tRNA^His^Δ~1~ substrate gave similar results ([Fig. 4A](#F4){ref-type="fig"}). All these results are consistent with the crystal structure and suggest that the β-hairpin plays an important role in anticodon-independent binding of the tRNA substrate. Residues in the β-hairpin are not well conserved, except for R215 (fig. S5). Mutants R215A and R215A/S213A, in which the completely conserved R215 was changed to alanine, showed a moderate effect on the activity (27.3 and 16.3%, respectively). Thus, specific interactions with the conserved R215 and van der Waals contacts to residues in the β-hairpin would be important for tRNA recognition.

![Mutational analysis of the β-hairpin and anticodon binding region.\
The rates of guanylylation by various mutants were measured. Error bars represent the SD of three independent experiments. (**A**) Guanylylation of ppptRNA^Phe^Δ~1~ and ppptRNA^His^Δ~1~ by various TLP mutants. The activity using \[α-^32^P\]GTP, wild-type *Ma*TLP, and ppptRNA^Phe^Δ~1~ is denoted as 100. (**B**) Guanylylation of tRNA^Phe^Δ~1~, tRNA^Phe^, and tRNA^His^Δ~−1~ by various TLP mutants. The activity to tRNA^Phe^Δ~1~ is about 10% of ppptRNA^Phe^Δ~1~.](1501397-F4){#F4}

Termination of the elongation reaction by measuring the accepter stem
---------------------------------------------------------------------

TLPs catalyze the Watson-Crick template--dependent elongation or repair reaction for 5′-end truncated tRNA^Phe^ substrates lacking G~1~ only (tRNA^Phe^Δ~1~), or lacking both G~1~ and G~2~ (tRNA^Phe^Δ~1,2~) ([@R11]), whereas they do not show any activity with intact tRNA^Phe^ (thus, repair is unnecessary). How TLP distinguishes between tRNAs that need 5′-end repair from ones that do not, or in other words, how the elongation reaction is properly terminated, remains unknown. The present structure of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex shows that, unlike Thg1, the TLP dimer binds one molecule of tRNA by recognizing the elbow region by the β-hairpin of molecule B and the 5′-end by molecule A. Therefore, we speculated that the flexible nature of the β-hairpin enables the recognition of tRNA substrates with different accepter stem lengths. To confirm this speculation, we used computer graphics to examine whether the β-hairpin region was able to bind tRNA substrates with different accepter stem lengths when the 5′-end was properly placed in the reaction site. When the 5′-end was placed in the reaction site, the body of the tRNA molecule shifted in a manner dependent on the accepter stem length. The tRNA body also rotated because of the helical nature of the accepter stem (fig. S7). This model structure showed that the accepter stem of intact tRNA^Phe^ was too long for the β-hairpin to recognize its elbow region, whereas tRNA^Phe^Δ~1~ and tRNA^Phe^Δ~1,2~ were recognized by the β-hairpin region (fig. S7), which is consistent with previous experiments ([@R11]). On the basis of these model structures, we concluded that the TLP molecule can properly terminate elongation by measuring the accepter stem length of tRNA substrates.

Dual binding mode for tRNA repair
---------------------------------

The present structural analysis revealed that although TLP and Thg1 have a similar tetrameric architecture, they have different binding modes for tRNAs: Thg1 is bound to tRNA^His^ as a tetramer, whereas TLP is bound to tRNA^Phe^ as a dimer. This difference in the tRNA binding modes is closely related to their enzymatic functions. The tRNA^His^-specific G~−1~ addition enzyme Thg1 needs to recognize both the accepter stem and anticodon of tRNA^His^. The tetrameric architecture of the Thg1 molecule allows it to access both regions located at the opposite side of the tRNA molecule \[the AB dimer recognizes the accepter stem and CD dimer anticodon ([@R19])\]. In contrast, the binding mode of TLP corresponds to the anticodon-independent repair reactions of 5′-truncated general tRNAs. This binding mode is also suitable for the correct termination of the elongation or repair reaction by measuring the length of the accepter stem by the flexible β-hairpin.

Because tRNA^His^ requires an extra guanosine (G~−1~) at the 5′-end, the repair enzyme has to extend the 5′-end by one more nucleotide than other tRNAs. TLP has been shown to confer such catalytic activity on tRNA^His^Δ~−1~ ([Fig. 4B](#F4){ref-type="fig"}) ([@R11]). Here, we showed that the TLP mutants, wherein the β-hairpin is truncated and tRNA^Phe^Δ~1~ binding ability is lost, can still bind to tRNA^Phe^ (GUG) whose anticodon is changed to that for His (fig. S6, C, H, and I). Also, the intact tRNA^Phe^, which is not recognized by TLP ([Fig. 4B](#F4){ref-type="fig"} and fig. S6E), can be recognized when its anticodon is changed to that for His (fig. S6D). Furthermore, the TLP variant (F174A/N179A/R188A) whose anticodon recognition site \[deduced from the Thg1-tRNA^His^ complex structure ([@R19])\] is disrupted has been shown to have a reduced catalytic activity to tRNA^His^Δ~−1~ ([Fig. 4B](#F4){ref-type="fig"}). All these experimental results indicate that TLP recognizes and binds tRNAs carrying the His anticodon in the same way that Thg1 recognizes tRNA^His^. Thus, we concluded that TLP has two tRNA binding modes that are selectively used, depending on both the length of the accepter stem and the anticodon. The elongation or repair reaction normally terminates when the 5′-end reaches position 1, but when the His anticodon is present, TLP binds the tRNA in the second mode by recognizing the anticodon to execute the G~−1~ addition reaction. By having two different binding modes, TLP can manage this special feature of tRNA^His^.

DISCUSSION
==========

The Thg1/TLP family of proteins extends tRNA chains in the 3′-5′ direction. The reaction involves two steps. First, the 5′-phosphate is activated by GTP/ATP. Then, the activated phosphate is attacked by the incoming nucleotide, resulting in an extension by one nucleotide at the 5′-end ([@R4], [@R14]). Here, we successfully solved for the first time the intermediate structures of the template-dependent 3′-5′ elongation complex of *Ma*TLP. On the basis of these structures, we will discuss the 3′-5′ addition reaction compared with canonical 5′-3′ elongation by DNA/RNA polymerases.

[Figure 5](#F5){ref-type="fig"} is a schematic diagram of the 3′-5′ addition reaction of TLP. This enzyme has two triphosphate binding sites and one reaction center at the position overlapping these two binding sites ([Fig. 5A](#F5){ref-type="fig"}). In the first activation step, when GTP/ATP is bound to site 1 ([Fig. 5B](#F5){ref-type="fig"}), the 5′-phosphate of the tRNA is deprotonated by Mg^2+^A and attacks the α-phosphate of the GTP/ATP, resulting in an activated intermediate ([Fig. 5C](#F5){ref-type="fig"}). The structure of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex, wherein β- and γ-phosphates coordinate with Mg^2+^A and Mg^2+^B, respectively ([Figs. 3A](#F3){ref-type="fig"} and [5C](#F5){ref-type="fig"}′), may represent this activated intermediate. Subsequent binding of an incoming nucleotide to site 2 followed by formation of the Watson-Crick base pair with a nucleotide in the template strand conveys the 3′-OH of the incoming nucleotide to the position of deprotonation by Mg^2+^A and the 5′-triphosphate of the tRNA to the reaction center ([Figs. 3B](#F3){ref-type="fig"} and [5D](#F5){ref-type="fig"}). Then, the elongation reaction of step 2 occurs ([Fig. 5E](#F5){ref-type="fig"}). Thus, the present structure shows that this 3′-5′ elongation enzyme utilizes a reaction center homologous to that of 5′-3′ elongation enzymes for both activation and elongation in a stepwise fashion. Although these two reactions are similar in chemistry, their substrate characteristics are very different. It should be noted that TLP has evolved to allow the occurrence of these two elaborate reaction steps within one reaction center.

![Schematic representation of the 3′-5′ elongation mechanism.\
(**A**) The reaction center overlapped with two triphosphate binding sites. A, B, and C (in green) represent binding sites for Mg^2+^A, Mg^2+^B, and Mg^2+^C. P (in blue) represents the phosphate binding sites; O^−^ (in red) is the binding site for the deprotonated OH group. Important TLP residues for tRNA and Mg^2+^ binding are also shown. (**B**) Structure of the activation complex (corresponding to fig. S8). GTP/ATP binds to triphosphate binding site 1; the deprotonated OH group of the 5′-phosphate attacks the α-phosphate of GTP/ATP, and PPi (inorganic pyrophosphate) is released. (**C**) Possible structure after the activation step as suggested from the structure of (C′). (**C**′) Structure before the elongation reaction (corresponding to [Fig. 3A](#F3){ref-type="fig"}). The 5′-triphosphate of the tRNA binds to the same site as for activation of the 5′-terminus of the tRNA in (B). (**D**) Structure of initiation of the elongation reaction (corresponding to [Fig. 3B](#F3){ref-type="fig"}). The base of the incoming GTP forms a Watson-Crick hydrogen bond with the nucleotide at position 72 in the template chain and a base-stacking interaction with a neighboring base (G2). Movement of the 5′-terminal chain leaves the 5′-triphosphate of the tRNA in the same site as the activation step in (B). The 3′-OH of the incoming GTP is deprotonated by Mg^2+^A and attacks the α-phosphate to form a covalent bond. (**E**) After the elongation reaction, the triphosphate of the new nucleotide is placed on site 1, as in (C′), and is ready for the next reaction.](1501397-F5){#F5}

[Figure 6](#F6){ref-type="fig"} compares the 3′-5′ and 5′-3′ elongation mechanisms, showing the symmetrical nature of both elongation reactions using a similar reaction center composed of Mg^2+^A and Mg^2+^B in the conserved catalytic core. In TLP, which carries out 3′-5′ elongation, the 3′-OH of the incoming nucleotide attacks the 5′-activated phosphate of the tRNA to form a phosphodiester bond, whereas in the T7 RNA polymerase, a representative 5′-3′ DNA/RNA polymerase, the 3′-OH of the 3′-terminal nucleotide of the RNA attacks the activated phosphate of the incoming nucleotide to form a phosphodiester bond. In these reactions, the roles of the two Mg ions are identical. Mg^2+^A activates the 3′-OH of the incoming nucleotide in TLP and the 3′-OH of the 3′-end of the RNA chain in T7 RNA polymerase. The role of Mg^2+^B is to position the 5′-triphosphate of the tRNA in TLP and the incoming nucleotide in T7 RNA polymerase. These two Mg^2+^ ions are coordinated by a conserved Asp (D21 and D69 in TLP) in the conserved catalytic core.

![Structures of template-dependent nucleotide elongation in the 3′-5′ and 5′-3′ directions.\
Symmetrical relationship between 3′-5′ elongation by TLP (this study) (left) and 5′-3′ elongation by T7 RNA polymerase **\[**Protein Data Bank (PDB) ID: 1S76\] (right). Red arrows represent elongation directions. In the 3′-5′ elongation reaction, the 3′-OH of the incoming nucleotide attacks the 5′-activated phosphate of the tRNA to form a phosphodiester bond, whereas in the 5′-3′ elongation reaction, the 3′-OH of the 3′-terminal nucleotide of the RNA attacks the activated phosphate of the incoming nucleotide to form a phosphodiester bond. Green spheres represent Mg^2+^ ions.](1501397-F6){#F6}

Because the chemical roles of tRNA and the incoming nucleotide are reversed in these two reactions, these two substrates are inserted into a similar reaction center from opposite directions ([Fig. 6](#F6){ref-type="fig"}). In spite of this difference, their fundamental reaction scheme is conserved. However, from an energetic viewpoint, these two reactions are clearly different: Whereas the high energy of the incoming nucleotide is used for its own addition in DNA/RNA polymerases, the high energy of the incoming nucleotide is used for subsequent addition in TLP. For this reason, TLP requires a mechanism that activates the 5′-terminus of the tRNA during the initial step of the reaction. Our analysis showed that the initial activation and subsequent elongation reactions occur sequentially at one reaction center. In this case, the enzyme needs to create two substrate binding sites for two different reactions in the vicinities of one reaction center. TLP has successfully created such sites by utilizing a conformational change in the tRNA through Watson-Crick base pairing ([Fig. 3](#F3){ref-type="fig"}). These structural features of the TLP molecule suggest that development of an activation reaction site is a prerequisite for developing the 3′-5′ elongation enzyme. This is clearly more difficult than developing the 5′-3′ elongation enzyme, wherein the activation reaction site is not necessary, and which may be the primary reason why the 5′-3′ elongation enzyme has been exclusively developed.

Here, we established a structural basis for 3′-5′ nucleotide elongation and showed that TLP has evolved to acquire a two-step Watson-Crick template--dependent 3′-5′ elongation reaction using the catalytic center homologous to 5′-3′ elongation enzymes. The active site of this enzyme is created at the dimerization interface. The dimerization also endows this protein with the ability to measure the length of the accepter stem of the tRNA substrate, so that the enzyme can properly terminate the elongation reaction. Furthermore, the dual binding mode of this protein suggests that it has further evolved to cover G~−1~ addition of tRNA^His^ by additional dimerization (dimer of dimers). Thus, the present structural analysis is consistent with the scenario in which TLP began as a 5′-end repair enzyme and evolved into a tRNA^His^-specific G~−1~ addition enzyme. The detailed molecular mechanism of the Thg1/TLP family established by our analysis will open up new perspectives in our understanding of 3′-5′ versus 5′-3′ polymerization and the molecular evolution of template-dependent polymerases.

MATERIALS AND METHODS
=====================

Plasmid construction
--------------------

Genomic DNA from *M. acetivorans* NBRC100939 was obtained from the NITE Biological Resource Center. The *Ma*TLP gene was amplified by polymerase chain reaction from genomic DNA. The DNA fragment encoding *Ma*TLP was then cloned between the Nde I and Xho I restriction sites in a pET26b vector with a C-terminal His tag. In the *Ma*TLP gene, the amber stop codon (UAG) at position 142 was translated as Pyl. To express the full-length *Ma*TLP in *Escherichia coli*, the TAG codon was altered to TGG (encoding Trp) with the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) as previously described ([@R9], [@R22]). The inserted sequence was verified by DNA sequencing.

Preparation of *Ma*TLP and mutants
----------------------------------

Plasmids were transformed into *E. coli* strain BL21 (DE3) pLysSRARE by electroporation, and cells were grown in LB medium containing kanamycin (25 μg/ml) and chloramphenicol (34 μg/ml) at 37°C until reaching an optical density at 600 nm (OD~600~) of 0.45. The cells were then induced by the addition of isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside to a final concentration of 250 μM and shifted to 18°C for approximately 20 hours before harvest. The cells were harvested and resuspended in buffer A \[50 mM Hepes-NaOH (pH 7.5), 1 M NaCl, 4 mM MgCl~2~, 10% glycerol, 0.5 mM β-mercaptoethanol, lysozyme (0.5 mg/ml), and deoxyibonuclease (0.1 mg/ml)\]. After sonication and centrifugation, the His~6~-tagged protein was purified by immobilized metal-ion affinity chromatography using a HisTrap HP column (GE Healthcare). The sample was washed with 75 mM imidazole and eluted with a 75 to 400 mM imidazole gradient in buffer B \[50 mM tris-HCl (pH 7.5), 500 mM NaCl, 4 mM MgCl~2~, 20% glycerol, and 0.5 mM β-mercaptoethanol\]. Then, the collected fractions were diluted in 300 mM NaCl with buffer C \[25 mM tris-HCl (pH 7.5), 10% glycerol, 5 mM MgCl~2~, and 1 mM dithiothreitol (DTT)\] and further purified on a HiTrap Heparin HP column (GE Healthcare) by elution with a 300 to 1000 mM NaCl gradient in buffer C. Finally, the protein was loaded onto a HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare) equilibrated with buffer D \[20 mM Hepes-NaOH (pH 7.5), 500 mM NaCl, 5 mM MgCl~2~, 10% glycerol, and 1 mM DTT\]. The protein was concentrated to 3.9 mg/ml by ultrafiltration. All *Ma*TLP mutants were constructed with the QuikChange Site-Directed Mutagenesis Kit. *Ma*TLP mutants were purified by a HisTrap HP column for RNA binding assay and further purified by a HiLoad 16/60 Superdex 200 prep grade column for 3′-5′ nucleotide addition assay.

Preparation of tRNA and its mutants
-----------------------------------

tRNA transcripts derived from yeast tRNA^Phe^ and tRNA^His^ were prepared using T7 RNA polymerase as previously described ([@R19]). ppptRNA transcripts were prepared by excluding guanosine 5′-monophosphate (GMP) from the reaction mixture. Transcribed tRNAs were purified by a HiTrap DEAE FF column (GE Healthcare) as previously described ([@R23]). Pooled tRNAs were precipitated with isopropanol and dissolved in buffer E \[20 mM Hepes-NaOH (pH 7.5), 100 mM NaCl, and 10 mM MgCl~2~\].

Preparation of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex
---------------------------------------------------

*Ma*TLP and ppptRNA^Phe^Δ~1~ (tRNA^Phe^ with a triphosphorylated 5′-end and deleted G~1~) were mixed in a molar ratio of 1.7:1 and incubated for 30 min at room temperature. The mixture was then loaded onto a HiLoad 16/60 Superdex 200 prep grade column equilibrated with buffer F \[20 mM Hepes-NaOH (pH 7.5), 400 mM NaCl, 5 mM MgCl~2~, 10% glycerol, and 1 mM DTT\]. Fractions containing the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex were mixed with 1 mM spermine and concentrated to an OD~280~ of 16 by ultrafiltration.

Crystallization and data collection
-----------------------------------

All crystallization experiments were performed with the sitting-drop vapor diffusion method at 293 K. Initial crystals of *Ma*TLP were obtained by mixing 1 μl of protein solution (3.9 mg/ml) with 1 μl of a reservoir solution containing 0.1 M Hepes-NaOH buffer (pH 7.5), 0.2 M magnesium chloride, and 30% polyethylene glycol 400 (PEG 400). *Ma*TLP-GTP complex crystals were obtained by soaking the *Ma*TLP crystals in the above reservoir solution supplemented with 1 mM GTP overnight. High-resolution crystals of *Ma*TLP in apo form (*Ma*TLP-apo) were obtained unexpectedly by mixing *Ma*TLP with tRNA^His^ in 0.1 M sodium/potassium phosphate (pH 6.2) containing 2.5 M NaCl. Crystals of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex were obtained from a solution containing 0.2 M tripotassium citrate, 0.1 M tris (pH 8.0), 37% PEG3350, and 10 mM praseodymium (III) acetate. Crystals of the *Ma*TLP-ppptRNA^Phe^Δ~1~-GDPNP complex were obtained by soaking *Ma*TLP-ppptRNA^Phe^Δ~1~ complex crystals in a reservoir solution containing 0.2 M tripotassium citrate, 0.1 M tris (pH 8.0), 30% PEG3350, 5% glycerol, and 15 mM GDPNP overnight. Crystals of *Ma*TLP-apo and *Ma*TLP-GTP were cryoprotected with a reservoir solution containing 50% PEG400 before flash-cooling, whereas crystals of the *Ma*TLP-ppptRNA^Phe^Δ~1~-GDPNP and *Ma*TLP-ppptRNA^Phe^Δ~1~ complexes were flash-cooled without any cryoprotectant under a stream of liquid nitrogen at 100 K. X-ray diffraction data were collected from beamline BL41XU at SPring-8 (Hyogo, Japan) and beamlines BL5A and BL17A at Photon Factory (Ibaraki, Japan). All diffraction data were indexed, integrated, scaled, and merged using XDS ([@R24]).

Structure determination and refinement
--------------------------------------

The crystal structure of *Ma*TLP-apo was determined by the molecular replacement (MR) method with Molrep ([@R25], [@R26]), using the protomer structure of *Ca*Thg1 (PDB ID: 3WBZ) ([@R19]) as a search model. The protomer structure of *Ma*TLP-apo was then used as a search model to solve the structures of *Ma*TLP-GTP. The crystal structure of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex was determined by the MR method with PHASER ([@R27]), using the protomer structures of *Ma*TLP-apo and tRNA^Phe^ from *Saccharomyces cerevisiae* (PDB ID: 1EHZ) ([@R28]) as search models. The structure of the *Ma*TLP-ppptRNA^Phe^Δ~1~ complex was then used as a search model to solve the *Ma*TLP-ppptRNA^Phe^Δ~1~-GDPNP complex structure. Initial protein models were fitted manually using Coot ([@R29]), and tRNA models were automatically rebuilt by LAFIRE_NAFIT ([@R30]); these models were then refined using phenix.refine ([@R31]). The data collection and refinement statistics are summarized in [Table 1](#T1){ref-type="table"}. All structure figures were generated by PyMol ([@R32]).

###### Summary of data collection and refinement statistics.

Values in parentheses are for the highest-resolution shell. PF, Photon Factory; Rmsd, root-mean-square deviation.

                                             ***Ma*TLP-apo**           ***Ma*TLP-GTP**           ***Ma*TLP-ppptRNA^Phe^Δ~1~**   ***Ma*TLP-ppptRNA^Phe^Δ~1~-GDPNP**
  ------------------------------------------ ------------------------- ------------------------- ------------------------------ ------------------------------------
  PDB ID                                     5AXK                      5AXL                      5AXM                           5AXN
  **Data collection**                                                                                                           
    Beamline                                 SPring-8 BL41XU           SPring-8 BL41XU           PF BL17A                       PF BL5A
    Space group                              *C*222~1~                 *C*222~1~                 *I*222                         *I*222
    Unit cell parameters *a*, *b*, *c* (Å)   98.3, 120.5, 157.4        103.1, 115.7, 144.9       75.3, 127.6, 143.8             82.3, 134.1, 147.4
    Wavelength (Å)                           0.9780                    1.0000                    0.97319                        1.0000
    Resolution range (Å)                     50.0--2.29 (2.43--2.29)   50.0--2.99 (3.17--2.99)   50.0--2.21 (2.34--2.21)        50.0--2.70 (2.87--2.70)
    *R*~meas~ (%)\*                          8.9 (76.3)                15.2 (90.0)               9.7 (74.4)                     11.0 (87.2)
    CC~1/2~ (%)                              99.8 (80.4)               99.5 (81.2)               99.9 (83.6)                    99.9 (83.5)
    〈*I*/σ(*I*)〉                           14.7 (2.8)                12.0 (2.6)                19.4 (3.2)                     16.9 (2.5)
    Completeness (%)                         98.3 (93.8)               98.8 (93.4)               99.7 (98.6)                    99.7 (99.3)
    Redundancy                               6.7 (6.6)                 7.2 (7.2)                 7.4 (7.3)                      8.1 (8.2)
  **Refinement**                                                                                                                
    No. of reflections                       41,650                    17,581                    35,102                         22,669
    *R*~work~/*R*~free~ (%)^†^               20.6/24.0                 21.5/25.3                 21.6/24.3                      22.5/26.7
    No. of atoms                                                                                                                
      Macromolecules                         3760                      3622                      5247                           5142
      Ligand/ion                             30                        68                        36                             101
      Water                                  89                        8                         102                            16
    *B*-factors (Å^2^)                                                                                                          
      Macromolecules                         57.0                      68.4                      45.3                           57.3
      Ligand/ion                             60.5                      86.2                      46.6                           59.9
      Water                                  49.0                      59.5                      33.0                           38.1
    Estimated coordinate error (Å)           0.32                      0.48                      0.25                           0.41
    Rmsd from ideal                                                                                                             
      Bond lengths (Å)                       0.009                     0.003                     0.003                          0.003
      Bond angles (°)                        1.11                      0.92                      0.72                           0.80

\**R*~meas~ = Σ~*hkl*~ {*N*(*hkl*)/\[*N*(*hkl*) − 1\]}^1/2^ Σ~*i*~ \| *I*~*i*~(*hkl*) − 〈*I*(*hkl*)〉 \|/Σ~*hkl*~ Σ~*i*~ *I*~*i*~(*hkl*), where 〈*I*(*hkl*)〉 and *N*(*hkl*) are the mean intensity of a set of equivalent reflections and the multiplicity, respectively.

†*R*~work~ *=* Σ~*hkl*~ \|\|*F*~obs~*\|* − *\|F*~calc~*\|\|*/Σ~*hkl*~ \|*F*~obs~*\|*; *R*~free~ was calculated for 5% randomly selected test sets that were not used in the refinement.

Nucleotide addition assay
-------------------------

Nucleotide addition assays were performed as previously described ([@R4]). A reaction mixture containing 25 mM Hepes-NaOH (pH 7.5), 400 mM NaCl, 10 mM MgCl~2~, 3 mM DTT, 5% glycerol, 0.1 μM \[α-^32^P\]GTP, 100 μM GTP, 1 μM *Ma*TLP variants, and 10 μM tRNA transcript was incubated at 30°C for 2 hours. Then, the reaction was quenched with phenol/chloroform, and the supernatant was resolved on a 10% polyacrylamide gel containing 8 M urea. The radioactivity was visualized with a BAS-1800 II bioimaging analyzer (Fujifilm).

tRNA binding assay
------------------

A reaction mixture containing 34 μM *Ma*TLP variants and 20 μM tRNA transcript was incubated in buffer F at room temperature for 30 min. Then, the mixture was loaded onto a Superdex 200 10/300 GL column (GE Healthcare) equilibrated with the same buffer.
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Fig. S1. Structure of *Ma*TLP-ppptRNA^Phe^Δ~1~ with the final 2*F*~o~ − *F*~c~ map.

Fig. S2. Comparison of the tRNA binding structures of *Ma*TLP and *Ca*Thg1.

Fig. S3. Stereo drawings of the *Ma*TLP active center.

Fig. S4. Structure of the active center in the *Ma*TLP-ppptRNA^Phe^Δ~1~-GDPNP complex superposed with an omit map.

Fig. S5. Multiple sequence alignment of Thg1/TLP enzymes.

Fig. S6. tRNA binding experiments using gel filtration.

Fig. S7. Binding models of TLP and tRNA truncation variants.

Fig. S8. A model of the active center in the activation complex.
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